Aducanumab, a new medication that clears plaques in the brain, may become one of the most promising treatments yet for early stages of Alzheimer’s disease, and there are indications that cognition losses can be reversed. The Guardian has a story by Ian Sample, here.
PBS Newshour has an even more detailed story, with comparative (to placebo) brain scans here , from Scientific American by Karen Weintraub.
The CBS video above (1 year old) discusses Alzheimer’s trials, as well as a malaria vaccine, and the idea that fathers tend to gain weight compared to non-fathers.
The new drug was reported on ABC World News Tonight Wednesday but the story is not yet up on ABC,